EDESA - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 and SOC versus Placebo and SOC in Adult Hospitalized Patients with COVID-19
Edesa Biotech Research
The purpose of this study is to evaluate the clinical efficacy and safety of EB05 and Standard of Care vs. Standard of Care alone in adult hospitalized patients with COVID-19. This is a Phase II/III study conducted in two stages: Stage 1 (Phase II) and Stage 2 (Phase III). Furthermore, some patients will be part of the Main Study and others will be part of the sub-study depending on their initial disease severity.
This study is currently enrolling.